These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37639010)
1. Clinical research progress on BRAF V600E-mutant advanced colorectal cancer. Zeng C; Wang M; Xie S; Wang N; Wang Z; Yi D; Kong F; Chen L J Cancer Res Clin Oncol; 2023 Nov; 149(17):16111-16121. PubMed ID: 37639010 [TBL] [Abstract][Full Text] [Related]
2. SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR Elez E; Kopetz S; Tabernero J; Bekaii-Saab T; Taieb J; Yoshino T; Manji G; Fernandez K; Abbattista A; Zhang X; Morris VK Future Oncol; 2024 Apr; 20(11):653-663. PubMed ID: 37815847 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study. Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218 [TBL] [Abstract][Full Text] [Related]
4. Impact of Metastasectomy in the Multimodality Approach for Johnson B; Jin Z; Truty MJ; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Grothey A Oncologist; 2018 Jan; 23(1):128-134. PubMed ID: 28904173 [TBL] [Abstract][Full Text] [Related]
5. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS. Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913 [TBL] [Abstract][Full Text] [Related]
7. Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer. Lee HM; Morris V; Napolitano S; Kopetz S Oncology (Williston Park); 2019 Jun; 33(6):206-11. PubMed ID: 31219603 [TBL] [Abstract][Full Text] [Related]
8. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431 [TBL] [Abstract][Full Text] [Related]
9. The Evolving Treatment Landscape in Tabernero J; Ros J; Élez E Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35503983 [TBL] [Abstract][Full Text] [Related]
10. Real-world first-line treatment of patients with BRAF Martinelli E; Cremolini C; Mazard T; Vidal J; Virchow I; Tougeron D; Cuyle PJ; Chibaudel B; Kim S; Ghanem I; Asselain B; Castagné C; Zkik A; Khan S; Arnold D ESMO Open; 2022 Dec; 7(6):100603. PubMed ID: 36368253 [TBL] [Abstract][Full Text] [Related]
15. Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAF García-Alfonso P; Lièvre A; Loupakis F; Tadmouri A; Khan S; Barcena L; Stintzing S Crit Rev Oncol Hematol; 2022 May; 173():103646. PubMed ID: 35344913 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of de la Fouchardière C; Cohen R; Malka D; Guimbaud R; Bourien H; Lièvre A; Cacheux W; Artru P; François E; Gilabert M; Samalin-Scalzi E; Zaanan A; Hautefeuille V; Rousseau B; Senellart H; Coriat R; Flippot R; Desseigne F; Lardy-Cleaud A; Tougeron D Oncologist; 2019 Dec; 24(12):e1331-e1340. PubMed ID: 31152084 [TBL] [Abstract][Full Text] [Related]
17. BRAF Gourdin G; Chotel L; de la Fouchardière C Adv Ther; 2023 Aug; 40(8):3281-3290. PubMed ID: 37316651 [TBL] [Abstract][Full Text] [Related]
18. Advances in the therapy of BRAF Jin Z; Sinicrope FA Expert Rev Anticancer Ther; 2019 Sep; 19(9):823-829. PubMed ID: 31455117 [No Abstract] [Full Text] [Related]
19. A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study. Eriksen M; Pfeiffer P; Rohrberg KS; Yde CW; Petersen LN; Poulsen LØ; Qvortrup C BMC Cancer; 2022 Dec; 22(1):1321. PubMed ID: 36527039 [TBL] [Abstract][Full Text] [Related]
20. Improvements in Clinical Outcomes for Morris VK; Bekaii-Saab T Clin Cancer Res; 2020 Sep; 26(17):4435-4441. PubMed ID: 32253230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]